DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Parenteral Drugs (India) Ltd (PDPL) share price today?

Parenteral Drugs (India) Ltd (PDPL) is trading at ₹4.25 on the NSE, down 4.49% on the day. Source: DocStoX.

What is the market capitalisation of Parenteral Drugs (India) Ltd?

Parenteral Drugs (India) Ltd has a market capitalisation of approximately ₹12 crore.

Parenteral Drugs (India) Ltd

PDPL·NSE·Healthcare

₹4.25▼ -0.20 (-4.49%)

⚠️Trading suspended — last traded ₹4.25 on 4 Dec 2022 (1322 days ago). Not a live price.

Healthcare · Pharmaceuticals & Biotechnology

A steady, established business

Open

₹4.25

High

₹4.25

Low

₹4.25

Prev Close

₹4.45

Volume

555

VWAP

₹4.25

Snapshot

Key fundamentals

Market Cap

₹12 Cr

P/E Ratio

N/A

P/B Ratio

N/A

EPS

₹-25.61

Book Value

N/A

ROE

N/A

ROCE

N/A

Dividend Yield

N/A

Debt / Equity

N/A

Face Value

₹10.00

52W High

N/A

52W Low

N/A

Sector

Healthcare

Industry

Pharmaceuticals & Biotechnology

Fairly Valued

None moatHigh uncertainty

Fair value unavailable

/100

Business quality — Solid

Growth 50Profitability 0Efficiency 50Valuation 50

Plain English

Our view

A steady, established business
Promoters hold a controlling stake

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

—

ROE

—

ROCE

—

Debt/Eq

—

Mkt Cap

₹12 Cr

P/B

—

EPS

₹-25.61

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

N/A

No P/E

Growth

Shrinking

-37% rev CAGR

Profitability

N/A

No ROE

Financial health

N/A

No debt data

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹2,359 Cr

Trades5

VWAP₹4.25

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-37.0%

-48.9%

10Y

-31.1%

Profit

—

10Y

—

EPS

—

10Y

—

Profile

Pros

Company has reduced debt.

Watch-outs

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -48.3% over past five years.
Contingent liabilities of Rs.135 Cr.
Company's cost of borrowing seems high

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2022

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

73%

Promoter

Promoters

73.3%+0.01

Public

26.7%0.00

DII

0.0%0.00

Total shareholders

7,129

Quarterly trend

Ownership over time

Q4 FY22

Promoter73.29%

DII0.01%

Public26.71%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1983, Parenteral Drugs Ltd is engaged in Manufacturing and Trading of Pharmaceutical Products